BDNF and androgen insensitivity syndrome: By employing a combination of clinical, histopathological, and in vitro experimental approaches, we seek to determine whether BDNF regulates the properties of fibrin thrombi and clarify its potential role as a novel therapeutic target in improving thrombolytic efficacy and clinical prognosis in diabetic patients with AIS.